Stoke Therapeutics, Inc(NASDAQ:STOK) 
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentat...
Website: http://www.stoketherapeutics.com
Founded: 2015
IPO Price: $18 (Jun 19, 2019)
Full Time Employees: 56
CEO: Edward M. Kaye
Sector: Healthcare
Industry: Biotechnology
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 1,402,000 | 10,632,000 | 13,817,000 | 158,569,000 | 22,614,000 | 4,894,000 | 4,831,000 | 4,216,000 | 2,802,000 | 3,308,000 | -2,481,000 | 5,152,000 | 3,268,000 | 2,905,000 | 3,231,000 | 3,000,000 | |||||||||||
yoy | -93.80% | 117.25% | 186.01% | 3661.12% | 707.07% | 47.94% | -294.72% | -18.17% | -14.26% | 13.87% | -176.79% | 71.73% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | |||||||
qoq | -86.81% | -23.05% | -91.29% | 601.20% | 362.08% | 1.30% | 14.59% | 50.46% | -15.30% | -233.33% | -148.16% | 57.65% | 12.50% | -10.09% | 7.70% | NaN% | NaN% | NaN% | NaN% | NaN% | |||||||
operating expenses: | |||||||||||||||||||||||||||
research and development | 41,695,000 | 37,696,000 | 25,855,000 | 32,676,000 | 23,423,000 | 22,205,000 | 21,136,000 | 22,368,000 | 21,778,000 | 20,271,000 | 20,551,000 | 19,631,000 | 21,060,000 | 20,109,000 | 18,358,000 | 18,309,000 | 15,802,000 | 14,358,000 | 14,095,000 | 9,913,000 | 8,904,000 | 8,109,000 | 7,968,000 | 7,215,000 | 7,089,000 | 6,518,000 | 6,023,000 |
sales, general and administrative | 21,146,000 | 16,027,000 | |||||||||||||||||||||||||
total operating expenses | 62,841,000 | 53,723,000 | 41,117,000 | 47,329,000 | 36,267,000 | 34,897,000 | 34,173,000 | 32,588,000 | 32,388,000 | 30,542,000 | 30,781,000 | 29,842,000 | 30,444,000 | 30,053,000 | 28,469,000 | 27,795,000 | 24,526,000 | 22,683,000 | 22,029,000 | 16,827,000 | 14,586,000 | 13,711,000 | 13,012,000 | 11,735,000 | 11,068,000 | 9,842,000 | 8,445,000 |
income from operations | -61,439,000 | -43,091,000 | -27,300,000 | 111,240,000 | -13,653,000 | -30,003,000 | -29,342,000 | -28,372,000 | -29,586,000 | -27,234,000 | -33,262,000 | -24,690,000 | -27,176,000 | -27,148,000 | -25,238,000 | -24,795,000 | -24,526,000 | -22,683,000 | -22,029,000 | -16,827,000 | -14,586,000 | -13,711,000 | -13,012,000 | -11,735,000 | -11,068,000 | -9,842,000 | -8,445,000 |
yoy | 350.00% | 43.62% | -6.96% | -492.08% | -53.85% | 10.17% | -11.79% | 14.91% | 8.87% | 0.32% | 31.79% | -0.42% | 10.80% | 19.68% | 14.57% | 47.35% | 68.15% | 65.44% | 69.30% | 43.39% | 31.79% | 39.31% | 54.08% | ||||
qoq | 42.58% | 57.84% | -124.54% | -914.77% | -54.49% | 2.25% | 3.42% | -4.10% | 8.64% | -18.12% | 34.72% | -9.15% | 0.10% | 7.57% | 1.79% | 1.10% | 8.13% | 2.97% | 30.91% | 15.36% | 6.38% | 5.37% | 10.88% | 6.03% | 12.46% | 16.54% | |
operating margin % | -4382.24% | -405.30% | -197.58% | 70.15% | -60.37% | -613.06% | -607.37% | -672.96% | -1055.89% | -823.28% | 1340.67% | -479.23% | -831.58% | -934.53% | -781.12% | -826.50% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% |
other income: | |||||||||||||||||||||||||||
interest income | 3,615,000 | 3,463,000 | 3,789,000 | 2,889,000 | 2,970,000 | 3,545,000 | 3,695,000 | 2,426,000 | 2,587,000 | 2,651,000 | 2,567,000 | 2,103,000 | 1,479,000 | 995,000 | 544,000 | 104,000 | 36,000 | 44,000 | 34,000 | 18,000 | 10,000 | 11,000 | 50,000 | 674,000 | 904,000 | 1,236,000 | 629,000 |
other income | -110,000 | 3,000 | 28,000 | 28,000 | 201,000 | 28,000 | -48,000 | -428,000 | 41,000 | 41,000 | 41,000 | 42,000 | 42,000 | 42,000 | 42,000 | 42,000 | 42,000 | 42,000 | 28,000 | 16,000 | 15,000 | 16,000 | 3,000 | 22,000 | 4,000 | 2,000 | |
total other income | 3,505,000 | 3,466,000 | 3,817,000 | 2,917,000 | 3,171,000 | 3,573,000 | 3,647,000 | 1,998,000 | 2,628,000 | 2,692,000 | 2,608,000 | 2,145,000 | 1,521,000 | 1,037,000 | 586,000 | 146,000 | 78,000 | 86,000 | 62,000 | 34,000 | 25,000 | 27,000 | 53,000 | 696,000 | 908,000 | 1,238,000 | 626,000 |
income before income taxes | 12,762,250 | -39,625,000 | -23,483,000 | 114,157,000 | |||||||||||||||||||||||
provision for income taxes | -1,278,000 | 1,278,000 | |||||||||||||||||||||||||
net income | -57,934,000 | -38,347,000 | -23,483,000 | 112,879,000 | -10,482,000 | -26,430,000 | -25,695,000 | -26,374,000 | -26,958,000 | -24,542,000 | -30,654,000 | -22,545,000 | -25,655,000 | -26,111,000 | -24,652,000 | -24,649,000 | -24,448,000 | -22,597,000 | -21,967,000 | -7,819,000 | |||||||
yoy | 452.70% | 45.09% | -8.61% | -527.99% | -61.12% | 7.69% | -16.18% | 16.98% | 5.08% | -6.01% | 24.35% | -8.54% | 4.94% | 15.55% | 12.22% | ||||||||||||
qoq | 51.08% | 63.30% | -120.80% | -1176.88% | -60.34% | 2.86% | -2.57% | -2.17% | 9.84% | -19.94% | 35.97% | -12.12% | -1.75% | 5.92% | 0.01% | 0.82% | 8.19% | 2.87% | |||||||||
net income margin % | -4132.24% | -360.68% | -169.96% | 71.19% | -46.35% | -540.05% | -531.88% | -625.57% | -962.10% | -741.90% | 1235.55% | -437.60% | -785.04% | -898.83% | -762.98% | -821.63% | -Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% |
net income per share | -0.17 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 | -0.66 | -0.67 | -0.61 | -0.6 | -0.46 | -0.42 | -0.41 | -0.39 | -0.34 | -0.09 | -0.26 | -1.54 | ||||
basic | 0.22 | -0.65 | -0.4 | 1.95 | |||||||||||||||||||||||
diluted | 0.213 | -0.65 | -0.4 | 1.9 | |||||||||||||||||||||||
weighted-average common shares outstanding: | |||||||||||||||||||||||||||
basic | 58,611,677 | 58,353,855 | 57,862,674 | ||||||||||||||||||||||||
diluted | 58,611,677 | 58,353,855 | 59,398,600 | ||||||||||||||||||||||||
comprehensive income: | |||||||||||||||||||||||||||
other comprehensive gain: | |||||||||||||||||||||||||||
unrealized gain on marketable securities | 97 | 350 | 200 | 47 | -317 | 181 | -15 | 24 | 123 | 232 | 219 | 577 | -383.75 | -427 | -516 | -5.5 | 20 | ||||||||||
total other comprehensive gain | 97 | 350 | 200 | 47 | -317 | 181 | -15 | 24 | |||||||||||||||||||
comprehensive income | 12,911.5 | -37,997 | -23,283 | 112,926 | |||||||||||||||||||||||
general and administrative | 15,262,000 | 14,653,000 | 12,844,000 | 12,692,000 | 13,037,000 | 10,220,000 | 10,610,000 | 10,271,000 | 10,230,000 | 10,211,000 | 9,384,000 | 9,944,000 | 10,111,000 | 9,486,000 | 8,724,000 | 8,325,000 | 7,934,000 | 6,914,000 | 5,682,000 | 5,602,000 | 5,044,000 | 4,520,000 | 3,979,000 | 3,324,000 | 2,422,000 | ||
net income per share | -0.17 | -0.47 | -0.46 | -0.57 | -0.6 | -0.55 | -0.69 | -0.53 | -0.65 | -0.66 | -0.63 | -0.66 | -0.67 | -0.61 | -0.6 | -0.46 | -0.42 | -0.41 | -0.39 | -0.34 | -0.09 | -0.26 | -1.54 | ||||
weighted-average common shares outstanding, basic and diluted | 56,341,074 | 55,765,948 | 46,246,889 | 44,266,017 | 44,188,464 | 42,536,474 | 39,420,310 | 39,258,358 | 37,448,301 | 36,759,319 | 36,708,188 | 36,643,205 | 33,273,597 | 33,054,656 | 32,897,395 | 32,707,647 | 5,083,620 | ||||||||||
comprehensive loss: | |||||||||||||||||||||||||||
comprehensive loss | -10,799 | -26,249 | -25,710 | -26,350 | -26,835 | -24,310 | -30,435 | -21,968 | -25,127 | -26,538 | -25,244 | -25,165 | -24,594 | -22,577 | -21,925 | ||||||||||||
total other comprehensive loss | 257 | 232 | 219 | 577 | 528 | -427 | -592 | -516 | -146 | 20 | -42 | ||||||||||||||||
other comprehensive loss: | |||||||||||||||||||||||||||
unrealized loss on marketable securities | -592 | -42 | |||||||||||||||||||||||||
net loss and comprehensive loss | -16,793,000 | -14,561,000 | -13,684,000 | -12,959,000 | -11,039,000 | -10,160,000 | -8,604,000 | ||||||||||||||||||||
other expense | -3,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||
cash and cash equivalents | 84,220,000 | 83,394,000 | 101,472,000 | 274,817,000 | 127,983,000 | 150,016,000 | 193,476,000 | 178,581,000 | 191,442,000 | 189,977,000 | 192,060,000 | 190,339,000 | 113,556,000 | 113,396,000 | 67,754,000 | 84,111,000 | 144,895,000 | 149,038,000 | 169,070,000 | 267,514,000 | 287,308,000 | 191,461,000 | 201,930,000 | 211,288,000 | 222,471,000 | 233,049,000 | 242,680,000 |
marketable securities - short term | 200,450,000 | 88,916,000 | |||||||||||||||||||||||||
accounts receivable | 5,936,000 | 9,248,000 | |||||||||||||||||||||||||
prepaid expenses | 8,736,000 | 7,747,000 | 13,694,000 | 12,694,000 | 11,117,000 | 9,837,000 | 10,345,000 | 10,722,000 | 11,320,000 | 10,936,000 | 10,950,000 | 10,191,000 | 10,932,000 | ||||||||||||||
other current assets | 3,895,000 | 5,543,000 | 6,871,000 | 5,037,000 | 3,965,000 | 3,809,000 | 4,287,000 | 3,559,000 | 2,561,000 | 4,269,000 | 3,699,000 | 5,880,000 | 2,955,000 | ||||||||||||||
restricted cash - short term | 494,000 | 75,000 | |||||||||||||||||||||||||
interest receivable | 1,969,000 | 1,589,000 | 1,622,000 | 606,000 | 700,000 | 691,000 | 305,000 | 11,000 | 64,000 | 96,000 | 136,000 | 492,000 | 588,000 | 395,000 | 350,000 | 265,000 | 132,000 | 45,000 | 131,000 | 6,000 | 6,000 | 2,000 | 9,000 | 144,000 | 281,000 | 376,000 | 260,000 |
total current assets | 305,700,000 | 272,437,000 | 269,970,000 | 375,736,000 | 232,756,000 | 253,612,000 | 296,994,000 | 193,275,000 | 215,339,000 | 230,019,000 | 246,232,000 | 270,236,000 | 244,070,000 | 264,601,000 | 289,159,000 | 305,771,000 | 229,218,000 | 244,933,000 | 260,233,000 | 275,295,000 | 293,930,000 | 195,456,000 | 205,544,000 | 215,774,000 | 226,033,000 | 236,680,000 | 244,445,000 |
restricted cash - long term | 227,000 | 721,000 | |||||||||||||||||||||||||
operating lease right-of-use assets | 3,101,000 | 3,708,000 | 3,218,000 | 3,831,000 | 4,345,000 | 4,928,000 | 5,499,000 | 6,060,000 | 6,611,000 | 3,084,000 | 3,646,000 | 4,202,000 | 4,753,000 | 5,295,000 | 5,831,000 | 4,563,000 | 4,939,000 | 5,326,000 | 1,258,000 | 844,000 | 1,115,000 | 1,381,000 | 1,642,000 | 1,900,000 | |||
marketable securities - long term | 106,260,000 | 29,824,000 | |||||||||||||||||||||||||
property and equipment | 3,146,000 | 3,083,000 | 3,343,000 | 3,611,000 | 3,909,000 | 4,333,000 | 4,770,000 | 5,278,000 | 5,823,000 | 6,217,000 | 6,472,000 | 6,789,000 | 6,675,000 | 7,161,000 | 5,868,000 | 5,035,000 | 4,139,000 | 2,943,000 | 2,884,000 | 2,711,000 | 2,675,000 | 2,893,000 | 2,823,000 | 2,962,000 | 2,512,000 | 1,942,000 | 1,722,000 |
total assets | 418,434,000 | 360,264,000 | 384,508,000 | 406,888,000 | 271,555,000 | 293,319,000 | 307,757,000 | 205,182,000 | 228,342,000 | 239,889,000 | 256,919,000 | 281,796,000 | 256,067,000 | 277,626,000 | 301,427,000 | 315,938,000 | 238,865,000 | 253,771,000 | 264,450,000 | 278,908,000 | 297,925,000 | 199,935,000 | 210,214,000 | 220,841,000 | 228,750,000 | 238,827,000 | 246,372,000 |
liabilities and stockholders’ equity | |||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||
accounts payable | 4,939,000 | 5,871,000 | 4,313,000 | 2,186,000 | 2,498,000 | 2,485,000 | 3,945,000 | 2,102,000 | 1,695,000 | 3,076,000 | 1,556,000 | 4,299,000 | 766,000 | 1,911,000 | 3,602,000 | 3,328,000 | 2,385,000 | 655,000 | 963,000 | 1,496,000 | 1,495,000 | 1,095,000 | 904,000 | 1,779,000 | 751,000 | 1,789,000 | 1,238,000 |
accrued and other current liabilities | 41,035,000 | 30,093,000 | 25,616,000 | 24,335,000 | 18,567,000 | 15,768,000 | 14,500,000 | 12,570,000 | 13,815,000 | 13,390,000 | 12,222,000 | 13,777,000 | 15,748,000 | 14,046,000 | 13,413,000 | 11,108,000 | 14,754,000 | 11,229,000 | 7,234,000 | 4,614,000 | 9,930,000 | 5,640,000 | 4,901,000 | 3,676,000 | 3,350,000 | 3,127,000 | 3,580,000 |
deferred revenue - current portion | 11,901,000 | 5,763,000 | 8,749,000 | 18,164,000 | 18,991,000 | 31,612,000 | 26,051,000 | 20,918,000 | 15,309,000 | 8,735,000 | 8,059,000 | 13,451,000 | 14,880,000 | 12,838,000 | 10,634,000 | 8,469,000 | |||||||||||
total current liabilities | 57,875,000 | 41,727,000 | 38,678,000 | 44,685,000 | 40,056,000 | 49,865,000 | 44,496,000 | 35,590,000 | 30,819,000 | 25,201,000 | 21,837,000 | 31,527,000 | 31,394,000 | 28,795,000 | 27,649,000 | 22,905,000 | 17,139,000 | 11,884,000 | 8,197,000 | 6,110,000 | 11,425,000 | 6,735,000 | 5,805,000 | 5,455,000 | 4,101,000 | 4,916,000 | 4,818,000 |
deferred revenue - net of current portion | 6,961,000 | 8,558,000 | 9,632,000 | 10,255,000 | 8,291,000 | 16,946,000 | 25,042,000 | 33,074,000 | 40,730,000 | 43,258,000 | 34,144,000 | 36,856,000 | 41,078,000 | 45,210,000 | 49,545,000 | ||||||||||||
other long term liabilities | 1,141,000 | 1,874,000 | 1,255,000 | 1,874,000 | 2,478,000 | 3,050,000 | 3,606,000 | 4,208,000 | 4,884,000 | 959,000 | 1,629,000 | 2,303,000 | 2,968,000 | 3,610,000 | 4,247,000 | 3,511,000 | |||||||||||
total long term liabilities | 8,102,000 | 10,432,000 | 10,887,000 | 12,129,000 | 2,478,000 | 11,341,000 | 20,552,000 | 29,250,000 | 37,958,000 | 41,689,000 | 44,887,000 | 36,447,000 | 39,824,000 | 44,688,000 | 49,457,000 | 53,056,000 | |||||||||||
total liabilities | 65,977,000 | 52,159,000 | 49,565,000 | 56,814,000 | 42,534,000 | 61,206,000 | 65,048,000 | 64,840,000 | 68,777,000 | 66,890,000 | 66,724,000 | 67,974,000 | 71,218,000 | 73,483,000 | 77,106,000 | 75,961,000 | 21,088,000 | 16,258,000 | 9,381,000 | 6,443,000 | 11,847,000 | 7,400,000 | 6,814,000 | 6,499,000 | 4,322,000 | 5,144,000 | 4,836,000 |
commitments and contingencies | |||||||||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||||||||
common stock | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
additional paid-in capital | 849,624,000 | 747,435,000 | 736,276,000 | 728,124,000 | 719,997,000 | 712,290,000 | 696,637,000 | 568,560,000 | 561,433,000 | 548,033,000 | 540,919,000 | 534,111,000 | 483,170,000 | 477,337,000 | 470,977,000 | 461,389,000 | 414,024,000 | 409,166,000 | 404,145,000 | 399,532,000 | 396,352,000 | 288,249,000 | 285,430,000 | 283,413,000 | 282,460,000 | 281,555,000 | 280,804,000 |
accumulated other comprehensive income | 543,000 | 446,000 | 96,000 | 166,000 | |||||||||||||||||||||||
accumulated deficit | -497,715,000 | -439,781,000 | -401,434,000 | -377,951,000 | -490,830,000 | -480,348,000 | -453,918,000 | -428,223,000 | -401,849,000 | -374,891,000 | -350,349,000 | -319,695,000 | -297,150,000 | -271,495,000 | -245,384,000 | -220,732,000 | -196,083,000 | -171,635,000 | -149,038,000 | -127,071,000 | -110,278,000 | -95,717,000 | -82,033,000 | -69,074,000 | -58,035,000 | -47,875,000 | -39,271,000 |
total stockholders’ equity | 352,457,000 | 308,105,000 | 334,943,000 | 350,074,000 | 229,021,000 | 232,113,000 | 242,709,000 | 140,342,000 | 159,565,000 | 172,999,000 | 190,195,000 | 213,822,000 | 184,849,000 | 204,143,000 | 224,321,000 | 239,977,000 | 217,777,000 | 237,513,000 | 255,069,000 | 272,465,000 | 286,078,000 | 192,535,000 | 203,400,000 | 214,342,000 | 224,428,000 | 233,683,000 | 241,536,000 |
total liabilities and stockholders’ equity | 418,434,000 | 360,264,000 | 384,508,000 | 406,888,000 | 271,555,000 | 293,319,000 | 307,757,000 | 205,182,000 | 228,342,000 | 239,889,000 | 256,919,000 | 281,796,000 | 256,067,000 | 277,626,000 | 301,427,000 | 315,938,000 | 238,865,000 | 253,771,000 | 264,450,000 | 278,908,000 | 297,925,000 | 199,935,000 | 210,214,000 | 220,841,000 | 228,750,000 | 238,827,000 | 246,372,000 |
marketable securities - current | 164,916,000 | 146,236,000 | 82,507,000 | 89,184,000 | |||||||||||||||||||||||
restricted cash - current | 75,000 | 75,000 | 75,000 | ||||||||||||||||||||||||
marketable securities - long-term | 80,315,000 | 107,256,000 | 22,989,000 | 29,952,000 | |||||||||||||||||||||||
restricted cash - long-term | 721,000 | 721,000 | 721,000 | 494,000 | 494,000 | ||||||||||||||||||||||
accumulated other comprehensive loss | -104,000 | -151,000 | -15,000 | -24,000 | -147,000 | -379,000 | -598,000 | -1,175,000 | -1,703,000 | -1,276,000 | -684,000 | -168,000 | -22,000 | -42,000 | |||||||||||||
marketable securities | 88,506,000 | 9,952,000 | 24,741,000 | 39,387,000 | 63,334,000 | 116,039,000 | 138,259,000 | 207,876,000 | 209,105,000 | 74,915,000 | 87,118,000 | 82,156,000 | |||||||||||||||
restricted cash - short-term | 75,000 | 147,000 | 147,000 | 147,000 | |||||||||||||||||||||||
deferred financing costs | 402,000 | 117,000 | 117,000 | 117,000 | 117,000 | 181,000 | 378,000 | 77,000 | |||||||||||||||||||
restricted cash | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 569,000 | 75,000 | 58,000 | 205,000 | 205,000 | 205,000 | 205,000 | 205,000 | 205,000 | 205,000 | |||||||
prepaid expenses and other current assets | 12,551,000 | 13,179,000 | 12,290,000 | 9,159,000 | 8,468,000 | 8,612,000 | 7,511,000 | 6,435,000 | 3,615,000 | 3,528,000 | 4,342,000 | 3,281,000 | 3,255,000 | 1,505,000 | |||||||||||||
long term liabilities | 3,949,000 | 4,374,000 | 1,184,000 | 333,000 | 422,000 | 665,000 | 1,009,000 | 1,044,000 | 221,000 | 228,000 | 18,000 | ||||||||||||||||
preferred stock, par value of 0.0001 per share; 10,000,000 shares authorized, none issued and outstanding as of december 31, 2019; and no shares authorized, issued or outstanding as of december 31, 2018 | |||||||||||||||||||||||||||
convertible preferred stock, par value of 0.0001 per share; no shares authorized, issued or outstanding at december 31, 2019; 225,584,874 shares authorized, 22,677,585 shares issued and outstanding as of december 31, 2018, aggregate liquidation preference of 130,850 at december 31, 2018 | |||||||||||||||||||||||||||
preferred stock, par value of 0.0001 per share; 10,000,000 shares authorized, none issued and outstanding as of september 30, 2019; and no shares authorized, issued or outstanding as of december 31, 2018 | |||||||||||||||||||||||||||
convertible preferred stock, par value of 0.0001 per share; no shares authorized, issued or outstanding at september 30, 2019; 22,677,585 shares issued and outstanding as of december 31, 2018; aggregate liquidation preference of 130,850 at december 31, 2018 | |||||||||||||||||||||||||||
preferred stock, par value of 0.0001 per share; 10,000,000 shares authorized, none issued and outstanding as of june 30, 2019; and none authorized as of december 31, 2018 | |||||||||||||||||||||||||||
convertible preferred stock, par value of 0.0001 per share; no shares authorized, issued or outstanding at june 30, 2019; 22,677,585 shares issued and outstanding as of december 31, 2018; aggregate liquidation preference of 130,850 at december 31, 2018 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||
net loss | -10,482,000 | -26,430,000 | -25,695,000 | -26,374,000 | -26,958,000 | -24,542,000 | -30,654,000 | -22,545,000 | -25,655,000 | -26,111,000 | -24,652,000 | -24,649,000 | -24,448,000 | -22,597,000 | -21,967,000 | -16,793,000 | -14,561,000 | -13,684,000 | -12,959,000 | -11,039,000 | -10,160,000 | -8,604,000 | ||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||||||||
depreciation | 405,000 | 442,000 | 446,000 | 477,000 | 526,000 | 540,000 | 548,000 | 563,000 | 624,000 | 637,000 | 611,000 | 597,000 | 609,000 | 388,000 | 302,000 | 247,000 | 235,000 | 254,000 | 249,000 | 236,000 | 237,000 | 234,000 | 224,000 | 193,000 | 139,000 | 126,000 |
amortization and accretion of marketable securities | -551,000 | -615,000 | 527,000 | -494,000 | -782,000 | -547,000 | -289,000 | -24,000 | -89,000 | -122,000 | -146,000 | 32,000 | -151,000 | -102,000 | -193,000 | 235,000 | 57,000 | 49,000 | ||||||||
stock-based compensation | 9,848,000 | 8,039,000 | 7,598,000 | 6,753,000 | 7,139,000 | 7,494,000 | 7,427,000 | 5,410,000 | 6,058,000 | 6,552,000 | 6,760,000 | 5,887,000 | 5,790,000 | 5,926,000 | 6,163,000 | 4,975,000 | 4,686,000 | 4,614,000 | 4,452,000 | 2,698,000 | 1,580,000 | 1,785,000 | 1,649,000 | 754,000 | 712,000 | 731,000 |
impairment of right of use asset | 0 | |||||||||||||||||||||||||
loss on disposal of property and equipment | 153,000 | 0 | 0 | 0 | 0 | 29,000 | 0 | 0 | 0 | 3,000 | ||||||||||||||||
reduction in the carrying amount of right of use assets | 650,000 | 547,000 | 612,000 | 599,000 | 582,000 | 571,000 | 562,000 | 550,000 | 591,000 | 563,000 | 556,000 | 550,000 | 543,000 | 536,000 | 533,000 | 377,000 | 386,000 | 322,000 | 277,000 | 271,000 | 266,000 | 262,000 | 257,000 | 253,000 | ||
changes in assets and liabilities: | ||||||||||||||||||||||||||
accounts receivable | 3,312,000 | |||||||||||||||||||||||||
prepaid expenses and other current assets | 220,000 | 5,640,000 | -3,850,000 | -2,555,000 | -1,443,000 | 600,000 | -644,000 | -349,000 | 1,353,000 | -514,000 | 1,778,000 | -2,088,000 | -1,528,000 | 581,000 | -971,000 | -3,265,000 | -778,000 | 228,000 | -1,223,000 | -1,078,000 | -2,823,000 | -80,000 | 949,000 | -924,000 | 863,000 | -1,866,000 |
accounts payable, accrued liabilities, and operating leases | ||||||||||||||||||||||||||
deferred revenue | 4,541,000 | -4,060,000 | -10,038,000 | 9,427,000 | -20,912,000 | -3,094,000 | -2,963,000 | -2,423,000 | -1,079,000 | -1,854,000 | 3,722,000 | -4,140,000 | -2,180,000 | -1,928,000 | -2,170,000 | 58,014,000 | ||||||||||
net cash from operating activities | -30,454,000 | -30,366,000 | -25,422,000 | 131,827,000 | -23,193,000 | -21,615,000 | -17,477,000 | -24,566,000 | -20,649,000 | -17,262,000 | -21,800,000 | -21,356,000 | -22,373,000 | -22,056,000 | -19,928,000 | 32,491,000 | -16,258,000 | -14,682,000 | -15,831,000 | -20,136,000 | -10,931,000 | -10,873,000 | -9,646,000 | -10,771,000 | -10,201,000 | -8,048,000 |
capital expenditures | -232,000 | -132,000 | -154,000 | -152,000 | -42,000 | -103,000 | -46,000 | -12,000 | -229,000 | -383,000 | -839,000 | -165,000 | -409,000 | -2,030,000 | -682,000 | -841,000 | -203,000 | -273,000 | -520,000 | -204,000 | -90,000 | -269,000 | -81,000 | -610,000 | -568,000 | -583,000 |
free cash flows | -30,686,000 | -30,498,000 | -25,576,000 | 131,675,000 | -23,235,000 | -21,718,000 | -17,523,000 | -24,578,000 | -20,878,000 | -17,645,000 | -22,639,000 | -21,521,000 | -22,782,000 | -24,086,000 | -20,610,000 | 31,650,000 | -16,461,000 | -14,955,000 | -16,351,000 | -20,340,000 | -11,021,000 | -11,142,000 | -9,727,000 | -11,381,000 | -10,769,000 | -8,631,000 |
cash flows from investing activities: | ||||||||||||||||||||||||||
purchases of property and equipment | -232,000 | -132,000 | -154,000 | -152,000 | -42,000 | -103,000 | -46,000 | -12,000 | -229,000 | -383,000 | -839,000 | -165,000 | -409,000 | -2,030,000 | -682,000 | -841,000 | -203,000 | -273,000 | -520,000 | -204,000 | -90,000 | -269,000 | -81,000 | -610,000 | -568,000 | -583,000 |
purchases of marketable securities | -98,228,000 | -23,925,000 | -181,553,000 | -19,016,000 | -29,139,000 | -49,901,000 | 4,870,000 | -9,706,000 | -52,543,000 | -143,941,000 | 0 | -4,991,000 | ||||||||||||||
sales of marketable securities | 37,399,000 | 33,151,000 | 33,230,000 | 32,800,000 | 30,000,000 | 20,000,000 | 0 | 10,000,000 | 15,000,000 | 15,000,000 | 24,312,000 | 53,250,000 | 18,029,000 | 79,000,000 | 53,371,000 | 9,000,000 | ||||||||||
net cash from investing activities | -61,061,000 | 9,094,000 | -148,477,000 | 13,632,000 | 819,000 | -30,004,000 | -88,278,000 | 9,988,000 | 14,771,000 | 14,617,000 | 23,473,000 | 53,085,000 | 22,490,000 | 67,264,000 | 146,000 | -135,782,000 | 11,797,000 | -5,264,000 | -82,755,000 | -204,000 | -90,000 | -269,000 | -81,000 | -610,000 | -569,000 | -583,000 |
cash flows from financing activities: | ||||||||||||||||||||||||||
proceeds from issuance of common stock upon exercise of stock options | 4,557,000 | 2,488,000 | 554,000 | 1,004,000 | 567,000 | 139,000 | 766,000 | 250,000 | 4,000 | 214,000 | -5,000 | 158,000 | 42,000 | 33,000 | 326,000 | 93,000 | 172,000 | 73,000 | 161,000 | 371,000 | 1,595,000 | 681,000 | 368,000 | 199,000 | 19,000 | |
proceeds from employee stock purchase plan | 0 | 632,000 | 0 | 370,000 | 0 | 364,000 | 0 | 168,000 | 1,000 | 348,000 | 53,000 | 153,000 | 0 | 401,000 | 0 | 169,000 | 0 | 334,000 | 0 | 175,000 | 0 | |||||
proceeds from controlled equity offering sales agreement, net of commissions | ||||||||||||||||||||||||||
proceeds from follow-on offering, net of underwriting discounts, commissions and offering costs | 0 | 0 | ||||||||||||||||||||||||
net cash from financing activities | 92,341,000 | 3,120,000 | 554,000 | 1,374,000 | 568,000 | 8,159,000 | 120,650,000 | 1,717,000 | 7,343,000 | 562,000 | 48,000 | 45,054,000 | 43,000 | 434,000 | 3,425,000 | 42,507,000 | 171,000 | 408,000 | 159,000 | 546,000 | 106,868,000 | 673,000 | 369,000 | 198,000 | 192,000 | -1,000,000 |
net decrease in cash, cash equivalents and restricted cash | 826,000 | 160,000 | 45,642,000 | -16,357,000 | -60,784,000 | -19,538,000 | -11,183,000 | |||||||||||||||||||
cash, cash equivalents and restricted cash—beginning of year | ||||||||||||||||||||||||||
cash, cash equivalents and restricted cash—end of year | ||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||||||||||||||
right-of-use assets recognized in exchange for operating leases | 0 | 0 | ||||||||||||||||||||||||
property and equipment included in accrued expense and accounts payable | 390,000 | 41,000 | 24,000 | 27,000 | 50,000 | 6,000 | 545,000 | -285,000 | -348,000 | 453,000 | 301,000 | 1,229,000 | 97,000 | -70,000 | 36,000 | 5,000 | 35,000 | |||||||||
net income | -38,348,000 | -23,482,000 | 112,879,000 | |||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||
accounts payable, accrued liabilities and lease liabilities | 4,881,000 | 2,765,000 | 4,741,000 | -749,000 | 3,577,000 | -1,919,000 | ||||||||||||||||||||
proceeds from issuance of common stock in controlled equity offering sales agreements | 7,656,000 | |||||||||||||||||||||||||
cash, cash equivalents and restricted cash—beginning of period | -1,000 | 0 | 128,780,000 | 0 | 0 | 192,011,000 | 0 | 0 | 114,125,000 | 0 | 0 | 145,464,000 | 0 | 0 | 287,513,000 | 0 | 0 | 222,676,000 | 0 | |||||||
cash, cash equivalents and restricted cash—end of period | -18,153,000 | -173,345,000 | 275,613,000 | -43,460,000 | 14,895,000 | 179,150,000 | -2,083,000 | 1,721,000 | 190,908,000 | 45,642,000 | -16,357,000 | 84,680,000 | -19,538,000 | -98,427,000 | 267,719,000 | -10,469,000 | -9,358,000 | 211,493,000 | -9,631,000 | |||||||
net increase in cash, cash equivalents and restricted cash | -173,345,000 | 146,833,000 | -21,806,000 | -43,460,000 | 14,895,000 | -12,861,000 | 1,465,000 | -2,083,000 | 1,721,000 | 76,783,000 | -19,794,000 | 95,847,000 | -10,469,000 | -10,578,000 | -9,631,000 | |||||||||||
deferred offering costs not yet paid | 402,000 | 145,000 | -60,000 | |||||||||||||||||||||||
proceeds from controlled equity offering sales agreements | 1,299,000 | 0 | 44,743,000 | 0 | ||||||||||||||||||||||
proceeds from controlled equity offering sales agreement | 7,338,000 | 42,245,000 | ||||||||||||||||||||||||
other | ||||||||||||||||||||||||||
accounts payable and accrued liabilities | 2,017,000 | -4,427,000 | 351,000 | 199,000 | -1,346,000 | 1,060,000 | -3,443,000 | 3,604,000 | 2,448,000 | 2,344,000 | -5,499,000 | 4,370,000 | 610,000 | 234,000 | -11,000 | -1,761,000 | 1,557,000 | |||||||||
proceeds from issuance of common stock upon public offerings | ||||||||||||||||||||||||||
payment of offering costs | ||||||||||||||||||||||||||
deferred financing costs | 181,000 | |||||||||||||||||||||||||
right-of-use assets recognized in exchange for operating leases under topic 842 | ||||||||||||||||||||||||||
payments of follow-on offering costs | 1,000 | |||||||||||||||||||||||||
right of use asset recognized in exchange for operating lease | ||||||||||||||||||||||||||
right-of-use assets recognized in exchange for operating leases upon adoption of topic 842 | 0 | 0 | 0 | 2,153,000 | ||||||||||||||||||||||
right-of-use asset recognized upon entering into amended lease | ||||||||||||||||||||||||||
payments on capital lease | -1,000 | |||||||||||||||||||||||||
deferred rent | 6,000 | 8,000 | ||||||||||||||||||||||||
proceeds from sale of property and equipment | -1,000 | 0 | ||||||||||||||||||||||||
proceeds from the issuance of common stock upon initial public offering | 0 | |||||||||||||||||||||||||
payments of initial public offering costs | 0 | -1,020,000 | ||||||||||||||||||||||||
proceeds from issuance of convertible preferred stock | ||||||||||||||||||||||||||
preferred stock issuance cost | ||||||||||||||||||||||||||
proceeds from issuance of common stock upon initial public offering | ||||||||||||||||||||||||||
proceeds from exercise of stock options | ||||||||||||||||||||||||||
property and equipment included in accrued expenses and accounts payable | ||||||||||||||||||||||||||
issuance of convertible preferred stock in exchange for simple agreement for future equity | ||||||||||||||||||||||||||
gain/loss on disposal of property and equipment | 0 |